Product image of Zutectra (Human Hepatitis B Immunoglobulin) supplied by GNH India

Zutectra

Active Ingredient:
Human Hepatitis B Immunoglobulin
Origin:
EU

Zutectra (Human Hepatitis B Immunoglobulin)

Zutectra is a human hepatitis B immunoglobulin used to prevent hepatitis B virus reinfection in liver transplant patients. This passive immunization provides rapid antibodies against HBV. Suitable for post-transplant prophylaxis.

Manufacturer / TM Owner

Biotest Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zutectra is used to prevent hepatitis B virus (HBV) reinfection in patients who have undergone liver transplantation due to HBV-related liver disease. It provides passive immunization by supplying antibodies against HBV, helping to maintain viral suppression during the critical post-transplant period. This medication is specifically indicated for individuals at high risk of HBV recurrence following liver transplant surgery.

Side Effects

  • Zutectra works by delivering pre-formed antibodies that bind to hepatitis B virus particles in the bloodstream. This action helps neutralize the virus and may reduce the likelihood of reinfection in transplant patients. The effects are temporary, as the body does not produce these antibodies itself, requiring regular administration to maintain protection.

Precautions & Warnings

  • Zutectra should be handled with care to avoid contamination or infection. It is administered via subcutaneous injection, typically under medical supervision. Patients should be monitored for signs of allergic reactions or infusion-related issues. Always inform healthcare providers about any known allergies or medical conditions before use.

Avoid Interactions

  • No specific drug interactions have been established for Zutectra. However, as with any immunoglobulin, caution is advised when administering live vaccines, as the antibodies may interfere with vaccine effectiveness. Consult a healthcare provider before combining with other medications or treatments.

Frequently Asked Questions

Zutectra is used to prevent hepatitis B virus reinfection in patients who have undergone liver transplantation.

Zutectra is given as a subcutaneous injection, typically under medical supervision.

Allergic reactions are possible with immunoglobulin products; patients should be monitored during administration.

Safety in pregnancy has not been established; consult a healthcare provider before use.

Zutectra is manufactured by Biotest Pharma GmbH in the European Union.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Hepatitis B Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT